The cytopathic activity of cholera toxin requires a threshold quantity of cytosolic toxin.


Journal

Cellular signalling
ISSN: 1873-3913
Titre abrégé: Cell Signal
Pays: England
ID NLM: 8904683

Informations de publication

Date de publication:
01 2023
Historique:
received: 11 09 2022
revised: 30 10 2022
accepted: 04 11 2022
pmc-release: 01 01 2024
pubmed: 13 11 2022
medline: 6 12 2022
entrez: 12 11 2022
Statut: ppublish

Résumé

After binding to the surface of a target cell, cholera toxin (CT) moves to the endoplasmic reticulum (ER) by retrograde transport. In the ER, the catalytic CTA1 subunit dissociates from the rest of the toxin and is transferred to the cytosol where it is degraded by a ubiquitin-independent proteasomal mechanism. However, CTA1 persists long enough to induce excessive cAMP production through the activation of Gsα. It is generally believed that only one or a few molecules of cytosolic CTA1 are necessary to elicit a cytopathic effect, yet no study has directly correlated the levels of cytosolic toxin to the extent of intoxication. Here, we used the technology of surface plasmon resonance to quantify the cytosolic pool of CTA1. Our data demonstrate that only 4% of surface-bound CTA1 is found in the cytosol after 2 h of intoxication. This represented around 2600 molecules of cytosolic toxin per cell, and it was sufficient to produce a robust cAMP response. However, we did not detect elevated cAMP levels in cells containing less than 700 molecules of cytosolic toxin. Thus, a threshold quantity of cytosolic CTA1 is required to elicit a cytopathic effect. When translocation to the cytosol was blocked soon after toxin exposure, the pool of CTA1 already in the cytosol was degraded and was not replenished. The cytosolic pool of CTA1 thus remained below its functional threshold, preventing the initiation of a cAMP response. These observations challenge the paradigm that extremely low levels of cytosolic toxin are sufficient for toxicity, and they provide experimental support for the development of post-intoxication therapeutic strategies.

Identifiants

pubmed: 36371029
pii: S0898-6568(22)00282-0
doi: 10.1016/j.cellsig.2022.110520
pmc: PMC9722578
mid: NIHMS1849821
pii:
doi:

Substances chimiques

Cholera Toxin 9012-63-9

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

110520

Subventions

Organisme : NIAID NIH HHS
ID : R21 AI105324
Pays : United States

Informations de copyright

Copyright © 2022 Elsevier Inc. All rights reserved.

Références

J Cell Biol. 2000 Mar 20;148(6):1203-12
pubmed: 10725333
PLoS Pathog. 2014 Feb 06;10(2):e1003925
pubmed: 24516389
Traffic. 2003 Apr;4(4):232-42
pubmed: 12694562
PLoS One. 2011 Apr 19;6(4):e18825
pubmed: 21526142
J Biol Chem. 1989 Apr 5;264(10):5352-7
pubmed: 2538415
Infect Immun. 2004 Dec;72(12):6826-35
pubmed: 15557603
Proc Natl Acad Sci U S A. 1985 Nov;82(22):7475-9
pubmed: 2999763
J Membr Biol. 1980;54(1):61-72
pubmed: 6259359
J Cell Biol. 2011 Nov 28;195(5):751-64
pubmed: 22123862
J Clin Invest. 1993 Dec;92(6):2941-51
pubmed: 8254049
Exp Cell Res. 1980 Apr;126(2):321-6
pubmed: 7363949
J Mol Biol. 2007 Dec 7;374(4):1114-28
pubmed: 17976649
Int J Mol Sci. 2019 Mar 15;20(6):
pubmed: 30875878
J Cell Biol. 1998 May 18;141(4):905-15
pubmed: 9585410
Infect Immun. 2016 Nov 18;84(12):3388-3398
pubmed: 27647866
J Cell Biol. 1992 Jun;117(6):1197-1209
pubmed: 1318883
Biosci Rep. 2018 Sep 7;38(5):
pubmed: 30135140
EMBO Rep. 2002 Dec;3(12):1222-7
pubmed: 12446567
Lancet. 2004 Jan 17;363(9404):223-33
pubmed: 14738797
J Mol Biol. 2009 Nov 13;393(5):1083-96
pubmed: 19748510
J Vis Exp. 2012 Jan 03;(59):e3686
pubmed: 22231143
Infect Immun. 2002 Nov;70(11):6172-9
pubmed: 12379695
Cell Mol Life Sci. 2008 May;65(9):1347-60
pubmed: 18278577
Mol Cell Biol. 2007 Aug;27(15):5534-43
pubmed: 17526733
Mol Membr Biol. 2004 Mar-Apr;21(2):77-92
pubmed: 15204437
Infect Immun. 1983 Dec;42(3):914-23
pubmed: 6196297
Biochem J. 1989 Sep 1;262(2):643-9
pubmed: 2508632
J Biol Chem. 1984 Jan 25;259(2):696-8
pubmed: 6582062
J Biol Chem. 2010 Feb 26;285(9):6145-52
pubmed: 20056601
Methods Mol Biol. 2009;544:201-29
pubmed: 19488702
Anal Bioanal Chem. 2003 Oct;377(3):528-39
pubmed: 12879189
Biochemistry. 1997 Sep 16;36(37):11051-4
pubmed: 9333321
J Biol Chem. 1982 Oct 25;257(20):12148-52
pubmed: 6288709
Mol Biol Cell. 2010 Jan 1;21(1):140-51
pubmed: 19864457
PLoS One. 2018 Nov 30;13(11):e0207693
pubmed: 30500844
J Biol Chem. 1989 Dec 25;264(36):21907-14
pubmed: 2557345
J Bacteriol. 1969 Jun;98(3):963-9
pubmed: 5788723
J Biol Chem. 1993 Jun 5;268(16):12010-6
pubmed: 8389369
J Biol Chem. 2011 Jun 24;286(25):22090-100
pubmed: 21543321
J Biol Chem. 2010 Oct 8;285(41):31261-7
pubmed: 20667832
Cell. 1978 Sep;15(1):245-50
pubmed: 699044
Nature. 1989 Aug 31;340(6236):692-6
pubmed: 2549426
Toxins (Basel). 2019 Aug 04;11(8):
pubmed: 31382673
J Cell Biol. 1982 Jun;93(3):860-5
pubmed: 6288736
Toxins (Basel). 2010 Mar;2(3):310-25
pubmed: 22069586

Auteurs

Carly Bader (C)

Burnett School of Biomedical Sciences, 12722 Research Parkway, University of Central Florida, Orlando, FL 32826, USA.

Michael Taylor (M)

Burnett School of Biomedical Sciences, 12722 Research Parkway, University of Central Florida, Orlando, FL 32826, USA.

Tuhina Banerjee (T)

Burnett School of Biomedical Sciences, 12722 Research Parkway, University of Central Florida, Orlando, FL 32826, USA. Electronic address: TBanerjee@MissouriState.edu.

Ken Teter (K)

Burnett School of Biomedical Sciences, 12722 Research Parkway, University of Central Florida, Orlando, FL 32826, USA. Electronic address: kteter@mail.ucf.edu.

Articles similaires

Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice
Animals Tail Swine Behavior, Animal Animal Husbandry

Classifications MeSH